Published on: 11/8/16
Philly.com reports on two Philadelphia medical schools collaborating on cannabidiol research. The aim of the universities is to encourage research and education initiatives involving physicians and scientists, and the research partners will co-present an academic conference on cannabis at the end of this month.
Thomas Jefferson University’s Center for Medical Cannabis Education and Research (CMCER) was launched on May 31 this year with a steering committee of 20 international experts on medical cannabis.
The mission of the CMCER is to advance the scientific basis, research efforts, educational opportunities, social innovation, and patient experience associated with the clinical use of cannabis-derived therapies.
The CMCER will provide accredited professional education for physicians and pharmacists regarding the potential uses of medical cannabis. Many states including Pennsylvania require professionals to receive such accredited education before registering to recommend medical cannabis to patients via registered dispensaries.
Stephen K. Klasko, MD, MBA, President and CEO of Thomas Jefferson University and Jefferson Health says Jefferson is a leader in innovation and the CMCER shows dedication to the ever-evolving nature of healthcare through understanding and researching cutting-edge methods for the treatment of disease. “This is a fundamental goal of the university and we are proud to be among the first to offer resources in support for the revolutionary expansion of medical marijuana.”
Charles Pollack, director of Jefferson’s CMCER center said the collaboration marks significant progress for the local research community as medical cannabis is a hot medical and social topic, and with institutions collaborating where they used to compete, things will be speeded up dramatically.
Patricia A. Epple, CEO, Pennsylvania Pharmacists Association said expert patient-focused pharmacists are crucial in the future dispensing of medical cannabis products. A new class of professionals will have to be created.
Putting heads together speed things up
“More ideas, more resources will get things done efficiently, these are very exciting times,” Pollack said.
Temple University is known for groundbreaking cannabinoid research. Sara Jane Ward, assistant professor of pharmacology at the university’s Lewis Katz School of Medicine says five faculty members are currently investigating the effects of cannabis compounds on the human body. They are working with compounds that are derived from the natural plant material, synthesized in the lab, or produced by the body itself.
The Carolina Cannabinoid Collaborative Conference 2016 is co-presented by the two institutions. The event is open to the public on registration, and the summit is expected to draw hundreds of the country’s leading cannabis researchers.
A selection of our products
This initiative might just be the beginning of the much-needed Cannabidiol research, which will spearhead the medical cannabis industry in a direction which will benefit patients all over the world. Indeed, these are very exciting times.
Disclaimer: Views expressed here do not necessarily reflect those of Endoca and its staff. This article is not intended to provide medical advice, diagnosis, treatment or cure. Endoca CBD products have not been approved by the US Food and Drug Administration (FDA).